British Journal of Oral and Maxillofacial Surgery
Volume 44, Issue 6 , Pages 482-486 , December 2006

The matrix metalloproteinase system in oral squamous cell carcinoma

  • E.A. Baker

      Affiliations

    • Professorial Unit of Surgery, University Hospital of North Tees, Stockton on Tees TS19 8PE, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 1642 624163; fax: +44 1642 624165.
    • ,
  • D.J. Leaper

      Affiliations

    • Professorial Unit of Surgery, University Hospital of North Tees, Stockton on Tees TS19 8PE, UK
    • ,
  • J.P. Hayter

      Affiliations

    • Maxillofacial Unit, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester, UK
    • ,
  • A.J. Dickenson

      Affiliations

    • Maxillofacial Unit, Derbyshire Royal Infirmary, Derby, UK

,Accepted 13 October 2005.

References 

  1. Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ. Matrix metalloproteinases. Br J Surg. 1997;84:160–166
  2. Sorsa T, Tjaderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis. 2004;10:311–318
  3. Raza SL, Cornelius LA. Matrix metalloproteinases: pro and anti-angiogenic activities. J Invest Dermatol Symp Proc. 2000;5:47–54
  4. Ray JM, Stetler-Stevenson WG. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J. 1995;7:2062–2072
  5. Ennis BW, Matrisian LM. Matrix degrading metalloproteinases. J Neurooncol. 1994;18:105–198
  6. Birkedal-Hansen B, Pavelic ZP, Gluckman JL, Stambrook P, Li Y-Q, Stetler-Stevenson WG. MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues. Oral Dis. 2000;6:376–382
  7. Guttman D, Stern Y, Shpitzer T, Ulanovski D, Druzd T, Feinmesser R. Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue. Oral Oncol. 2004;40:798–803
  8. Yoshizaki T, Sato H, Maryama Y, Murono S, Furukawa M, Park SC, et al. Increased expression of membrane type-1 matrix metalloproteinase in head and neck carcinoma. Cancer. 1997;79:139–144
  9. Rosenthal EL, Hotary K, Bradford C, Weiss SJ. Role of membrane type-1-matrix metalloproteinase and gelatinase A in head and neck squamous cell carcinoma invasion in vitro. Otolaryngol Head Neck Surg. 1999;12:337–343
  10. Ikebe T, Shinohara M, Takeuchi H, Beppu M, Kurahara S, Nakamura S, et al. Gelatinolytic activity of matrix metalloproteinase in tumour tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis. 1999;17:315–323
  11. Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. Am J Clin Pathol. 1993;99:18–23
  12. Kusukawa J, Sasaguri Y, Morimatsu M, Kameyama T. Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity. J Oral Maxillofac Surg. 1995;53:530–534
  13. Pacheco MM, Kowalski LP, Nishimoto IN, Brentani MM. Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B and matrilysin mRNAs. Head Neck. 2002;24:24–32
  14. Franchi A, Santucci M, Masini E, Sardi I, Pagierani M, Gallo O. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2 and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer. 2002;95:1902–1910
  15. Nagel H, Lasakawi R, Wahlers A, Hemmerlein B. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2 and -3 in benign and malignant tumours of the salivary gland. Histopathology. 2004;44:222–231
  16. Ikebe T, Shinohara M, Takeuchi H, et al. Gelatinocytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis. 1999;17:315–323
  17. Katayama A, Bandoh N, Kishibe K, et al. Expressions of matrix metalloproteinases in early stage oral squamous cell carcinoma as predictive indicators for tumour metastases and prognosis. Clin Cancer Res. 2004;10:634–640
  18. Kurahara SI, Shinohara M, Ikebe T, et al. Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumour invasion and metastasis. Head Neck. 1999;21:627–638
  19. Ohnishi ST, Barr JK. A simplified method of quantifying proteins using the biuret and phenol reagents. Anal Biochem. 1978;86:193–200
  20. Baker EA, Leaper DJ. Measuring gelatinase activity in colorectal cancer. Eur J Surg Oncol. 2002;28:24–29
  21. Knight CG, Willenbrock F, Murphy G. A novel coumarin labelled peptide for sensitive continuous assays of matrix metalloproteinases. FEBS Lett. 1992;296:263–266
  22. Garbett EA, Reed MWR , Brown NJ. Proteolysis in colorectal cancer. Mol Pathol. 1999;52:140–145
  23. Schmidt M, Polednik C, Hoppe F. Proteolytic patterns of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 1999;256:346–350
  24. Kayano K, Shimada T, Shinomiya T, et al. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2. J Pathol. 2004;202:403–411
  25. Sutinen M, Kainulainen T, Hurskainen T, et al. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer. 1998;77:2239–2245
  26. Culhaci N, Metin K, Copcu E, Dikicioglu E. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness. BMC Cancer. 2004;4:42
  27. Myoung H, Kim MJ, Hong SD, et al. Expression of membrane type 1-matrix metalloproteinase in oral squamous cell carcinoma. Cancer Lett. 2002;185:201–209
  28. Shimada T, Nakamura H, Yamashita K, et al. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: Implications for lymph node metastasis. Clin Exp Metastasis. 2000;18:179–188
  29. Thomas GT, Lewis MP, Speight PM. Matrix metalloproteinases and oral cancer. Oral Oncol. 1999;35:227–233

PII: S0266-4356(05)00322-0

doi: 10.1016/j.bjoms.2005.10.005

British Journal of Oral and Maxillofacial Surgery
Volume 44, Issue 6 , Pages 482-486 , December 2006

Article Tools

* Image Usage & Resolution